Related Content
Search Google Scholar for:
|
|
Science 27 June 1986: Vol. 232. no. 4758, pp. 1629 - 1632 DOI: 10.1126/science.3487117
|
|
Articles
Science, Vol 232, Issue 4758, 1629-1632
Copyright © 1986 by American Association for the Advancement of Science
Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking
M Brownlee,
H Vlassara,
A Kooney,
P Ulrich,
and
A Cerami
Age-associated increases in collagen cross-linking and accumulation of advanced glycosylation products are both accelerated by diabetes, suggesting that glucose-derived cross-link formation may contribute to the development of chronic diabetic complications as well as certain physical changes of aging. Aminoguanidine, a nucleophilic hydrazine compound, prevented both the formation of fluorescent advanced nonenzymatic glycosylation products and the formation of glucose-derived collagen cross-links in vitro. Aminoguanidine administration to rats was equally effective in preventing diabetes-induced formation of fluorescent advanced nonenzymatic glycosylation products and cross-linking of arterial wall connective tissue protein in vivo. The identification of aminoguanidine as an inhibitor of advanced nonenzymatic glycosylation product formation now makes possible precise experimental definition of the pathogenetic significance of this process and suggests a potential clinical role for aminoguanidine in the future treatment of chronic diabetic complications.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- A Novel Sartan Derivative With Very Low Angiotensin II Type 1 Receptor Affinity Protects the Kidney in Type 2 Diabetic Rats.
- Y. Izuhara, T. Sada, H. Yanagisawa, H. Koike, S. Ohtomo, T. Dan, S. Ito, M. Nangaku, C. van Ypersele de Strihou, and T. Miyata (2008)
Arterioscler. Thromb. Vasc. Biol.
28, 1767-1773
| Abstract »
| Full Text »
| PDF »
- The Role of Advanced Glycation End Products in Progression and Complications of Diabetes.
- S.-Y. Goh and M. E. Cooper (2008)
J. Clin. Endocrinol. Metab.
93, 1143-1152
| Abstract »
| Full Text »
| PDF »
- A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor.
- S. M. Grundy (2008)
Eur. Heart J. Suppl.
10, B16-B23
| Abstract »
| Full Text »
| PDF »
- A novel class of advanced glycation inhibitors ameliorates renal and cardiovascular damage in experimental rat models.
- Y. Izuhara, M. Nangaku, S. Takizawa, S. Takahashi, J. Shao, H. Oishi, H. Kobayashi, C. van Ypersele de Strihou, and T. Miyata (2008)
Nephrol. Dial. Transplant.
23, 497-509
| Abstract »
| Full Text »
| PDF »
- Evidence for in Vivo Scavenging by Aminoguanidine of Formaldehyde Produced via Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination.
- M. Kazachkov, K. Chen, S. Babiy, and P. H. Yu (2007)
J. Pharmacol. Exp. Ther.
322, 1201-1207
| Abstract »
| Full Text »
| PDF »
- Association between glycosylated hemoglobin, left ventricular mass and aortic function in nondiabetic individuals with insulin resistance.
- D. A Stakos, D. P Schuster, E. A Sparks, S. B. Meis, C. F Wooley, K. Osei, and H. Boudoulas (2007)
Eur. J. Endocrinol.
157, 63-68
| Abstract »
| Full Text »
| PDF »
- Methylglyoxal Inhibits the Binding Step of Collagen Phagocytosis.
- S. A. C. Chong, W. Lee, P. D. Arora, C. Laschinger, E. W. K. Young, C. A. Simmons, M. Manolson, J. Sodek, and C. A. McCulloch (2007)
J. Biol. Chem.
282, 8510-8520
| Abstract »
| Full Text »
| PDF »
- Combination Therapy with the Advanced Glycation End Product Cross-Link Breaker, Alagebrium, and Angiotensin Converting Enzyme Inhibitors in Diabetes: Synergy or Redundancy?.
- M. T. Coughlan, V. Thallas-Bonke, J. Pete, D. M. Long, A. Gasser, D. C. K. Tong, M. Arnstein, S. R. Thorpe, M. E. Cooper, and J. M. Forbes (2007)
Endocrinology
148, 886-895
| Abstract »
| Full Text »
| PDF »
- Diabetes and Advanced Glycoxidation End Products..
- A. G. Huebschmann, J. G. Regensteiner, H. Vlassara, and J. E.B. Reusch (2006)
Diabetes Care
29, 1420-1432
| Full Text »
| PDF »
- Advanced Glycation End Products Inhibit Tubulogenesis and Migration of Kidney Epithelial Cells in an Ezrin-Dependent Manner.
- M. A Gallicchio, E. A. McRobert, A. Tikoo, M. E. Cooper, and L. A. Bach (2006)
J. Am. Soc. Nephrol.
17, 414-421
| Abstract »
| Full Text »
| PDF »
- Advanced glycation end products and the kidney.
- J. M. Bohlender, S. Franke, G. Stein, and G. Wolf (2005)
Am J Physiol Renal Physiol
289, F645-F659
| Abstract »
| Full Text »
| PDF »
- Glucosepane Is a Major Protein Cross-link of the Senescent Human Extracellular Matrix: RELATIONSHIP WITH DIABETES.
- D. R. Sell, K. M. Biemel, O. Reihl, M. O. Lederer, C. M. Strauch, and V. M. Monnier (2005)
J. Biol. Chem.
280, 12310-12315
| Abstract »
| Full Text »
| PDF »
- Aminoguanidine Prevents Fructose-Induced Arterial Stiffening in Wistar Rats: Aortic Impedance Analysis.
- Y.-T. Lin, Y.-Z. Tseng, and K.-C. Chang (2004)
Experimental Biology and Medicine
229, 1038-1045
| Abstract »
| Full Text »
| PDF »
- Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.
- G. Basta, A. M. Schmidt, and R. De Caterina (2004)
Cardiovasc Res
63, 582-592
| Abstract »
| Full Text »
| PDF »
- Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis.
- J. M. Forbes, L. T. L. Yee, V. Thallas, M. Lassila, R. Candido, K. A. Jandeleit-Dahm, M. C. Thomas, W. C. Burns, E. K. Deemer, S. R. Thorpe, et al. (2004)
Diabetes
53, 1813-1823
| Abstract »
| Full Text »
| PDF »
- Diabetic Retinopathy.
- R. N. Frank (2004)
N. Engl. J. Med.
350, 48-58
| Full Text »
| PDF »
- Modification of Proteins In Vitro by Physiological Levels of Glucose: PYRIDOXAMINE INHIBITS CONVERSION OF AMADORI INTERMEDIATE TO ADVANCED GLYCATION END-PRODUCTS THROUGH BINDING OF REDOX METAL IONS.
- P. A. Voziyan, R. G. Khalifah, C. Thibaudeau, A. Yildiz, J. Jacob, A. S. Serianni, and B. G. Hudson (2003)
J. Biol. Chem.
278, 46616-46624
| Abstract »
| Full Text »
| PDF »
- The Amino-terminal Domains of the Ezrin, Radixin, and Moesin (ERM) Proteins Bind Advanced Glycation End Products, an Interaction That May Play a Role in the Development of Diabetic Complications.
- E. A. McRobert, M. Gallicchio, G. Jerums, M. E. Cooper, and L. A. Bach (2003)
J. Biol. Chem.
278, 25783-25789
| Abstract »
| Full Text »
| PDF »
- Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy.
- K. L. Herrmann, A. D. McCulloch, and J. H. Omens (2003)
Am J Physiol Heart Circ Physiol
284, H1277-H1284
| Abstract »
| Full Text »
| PDF »
- Collagen cross-linking: new dimension to cardiac remodeling.
- S. K.G Koshy, H. K Reddy, and H. H Shukla (2003)
Cardiovasc Res
57, 594-598
| Full Text »
| PDF »
- Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats.
- D. Badenhorst, M. Maseko, O. J Tsotetsi, A. Naidoo, R. Brooksbank, G. R Norton, and A. J Woodiwiss (2003)
Cardiovasc Res
57, 632-641
| Abstract »
| Full Text »
| PDF »
- Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies.
- Z. He, C. Rask-Madsen, and G.L. King (2003)
Eur. Heart J. Suppl.
5, B51-B57
| Abstract »
| PDF »
- Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications.
- M. J. Sheetz and G. L. King (2002)
JAMA
288, 2579-2588
| Abstract »
| Full Text »
| PDF »
- Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy.
- H. Vlassara, W. Cai, J. Crandall, T. Goldberg, R. Oberstein, V. Dardaine, M. Peppa, and E. J. Rayfield (2002)
PNAS
99, 15596-15601
| Abstract »
| Full Text »
| PDF »
- Glycation by Ascorbic Acid Causes Loss of Activity of Ribulose-1,5-Bisphosphate Carboxylase/Oxygenase and Its Increased Susceptibility to Proteases.
- Y. Yamauchi, Y. Ejiri, and K. Tanaka (2002)
Plant Cell Physiol.
43, 1334-1341
| Abstract »
| Full Text »
| PDF »
- Reduction of the Accumulation of Advanced Glycation End Products by ACE Inhibition in Experimental Diabetic Nephropathy.
- J. M. Forbes, M. E. Cooper, V. Thallas, W. C. Burns, M. C. Thomas, G. C. Brammar, F. Lee, S. L. Grant, L. A. Burrell, G. Jerums, et al. (2002)
Diabetes
51, 3274-3282
| Abstract »
| Full Text »
| PDF »
- Angiotensin II Receptor Antagonists and Angiotensin-Converting Enzyme Inhibitors Lower In Vitro the Formation of Advanced Glycation End Products: Biochemical Mechanisms.
- T. Miyata, C. van Ypersele de Strihou, Y. Ueda, K. Ichimori, R. Inagi, H. Onogi, N. Ishikawa, M. Nangaku, and K. Kurokawa (2002)
J. Am. Soc. Nephrol.
13, 2478-2487
| Abstract »
| Full Text »
| PDF »
- Peroxynitrite Induces Formation of N{varepsilon}-(Carboxymethyl)Lysine by the Cleavage of Amadori Product and Generation of Glucosone and Glyoxal From Glucose: Novel Pathways for Protein Modification by Peroxynitrite.
- R. Nagai, Y. Unno, M. C. Hayashi, S. Masuda, F. Hayase, N. Kinae, and S. Horiuchi (2002)
Diabetes
51, 2833-2839
| Abstract »
| Full Text »
| PDF »
- Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart.
- K. Yamamoto, T. Masuyama, Y. Sakata, N. Nishikawa, T. Mano, J. Yoshida, T. Miwa, M. Sugawara, Y. Yamaguchi, T. Ookawara, et al. (2002)
Cardiovasc Res
55, 76-82
| Abstract »
| Full Text »
| PDF »
- A Post-Amadori Inhibitor Pyridoxamine Also Inhibits Chemical Modification of Proteins by Scavenging Carbonyl Intermediates of Carbohydrate and Lipid Degradation.
- P. A. Voziyan, T. O. Metz, J. W. Baynes, and B. G. Hudson (2002)
J. Biol. Chem.
277, 3397-3403
| Abstract »
| Full Text »
| PDF »
- Aminoguanidine and Aortic Wall Mechanics, Structure, and Composition in Aged Rats.
- C. Cantini, P. Kieffer, B. Corman, P. Liminana, J. Atkinson, and I. Lartaud-Idjouadiene (2001)
Hypertension
38, 943-948
| Abstract »
| Full Text »
| PDF »
- Effect of Chronic Aminoguanidine Treatment on Age-Related Glycation, Glycoxidation, and Collagen Cross-linking in the Fischer 344 Rat.
- D. R. Sell, J. F. Nelson, and V. M. Monnier (2001)
J. Gerontol. A Biol. Sci. Med. Sci.
56, B405-411
| Abstract »
| Full Text »
| PDF »
- Glucose and Palmitic Acid Induce Degeneration of Myofibrils and Modulate Apoptosis in Rat Adult Cardiomyocytes.
- D. Dyntar, M. Eppenberger-Eberhardt, K. Maedler, M. Pruschy, H. M. Eppenberger, G. A. Spinas, and M. Y. Donath (2001)
Diabetes
50, 2105-2113
| Abstract »
| Full Text »
| PDF »
- Abnormalities of Retinal Metabolism in Diabetes and Experimental Galactosemia: VII. Effect of Long-Term Administration of Antioxidants on the Development of Retinopathy.
- R. A. Kowluru, J. Tang, and T. S. Kern (2001)
Diabetes
50, 1938-1942
| Abstract »
| Full Text »
| PDF »
- The Diabetic Foot : Basic Mechanisms of Disease.
- G. P. Guyton and C. L. Saltzman (2001)
J. Bone Joint Surg. Am.
83, 1083-1096
| Full Text »
- Pharmacological Inhibition of Diabetic Retinopathy: Aminoguanidine and Aspirin.
- T. S. Kern and R. L. Engerman (2001)
Diabetes
50, 1636-1642
| Abstract »
| Full Text »
| PDF »
- Advanced glycation: an important pathological event in diabetic and age related ocular disease.
- A. W STITT (2001)
Br. J. Ophthalmol.
85, 746-753
| Full Text »
| PDF »
- Reduction in Myocardial Collagen Cross-Linking Parallels Left Ventricular Dilatation in Rat Models of Systolic Chamber Dysfunction.
- A. J. Woodiwiss, O. J. Tsotetsi, S. Sprott, E. J. Lancaster, T. Mela, E. S. Chung, T. E. Meyer, and G. R. Norton (2001)
Circulation
103, 155-160
| Abstract »
| Full Text »
| PDF »
- Mechanism of the Inhibitory Effect of OPB-9195 [({+/-})-2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide] on Advanced Glycation End Product and Advanced Lipoxidation End Product Formation.
- T. MIYATA, Y. UEDA, K. ASAHI, Y. IZUHARA, R. INAGI, A. SAITO, C. VAN YPERSELE DE STRIHOU, and K. KUROKAWA (2000)
J. Am. Soc. Nephrol.
11, 1719-1725
| Abstract »
| Full Text »
- Advanced Glycation and Lipoxidation End Products: Role of Reactive Carbonyl Compounds Generated during Carbohydrate and Lipid Metabolism.
- T. MIYATA, K. KUROKAWA, and C. VAN YPERSELE DE STRIHOU (2000)
J. Am. Soc. Nephrol.
11, 1744-1752
| Full Text »
- Food Restriction Prevents Advanced Glycation End Product Accumulation and Retards Kidney Aging in Lean Rats.
- L. TEILLET, P. VERBEKE, S. GOURAUD, H. BAKALA, C. BOROT-LALOI, D. HEUDES, P. BRUNEVAL, and B. CORMAN (2000)
J. Am. Soc. Nephrol.
11, 1488-1497
| Abstract »
| Full Text »
- Molecular basis for a link between complement and the vascular complications of diabetes.
- J. Acosta, J. Hettinga, R. Fluckiger, N. Krumrei, A. Goldfine, L. Angarita, and J. Halperin (2000)
PNAS
97, 5450-5455
| Abstract »
| Full Text »
| PDF »
- Treatment of Diabetic Retinopathy.
- F. L. Ferris, M. D. Davis, and L. M. Aiello (1999)
N. Engl. J. Med.
341, 667-678
| Full Text »
| PDF »
- Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma.
- A. H. Neufeld, A. Sawada, and B. Becker (1999)
PNAS
96, 9944-9948
| Abstract »
| Full Text »
| PDF »
- Immunohistochemical Evidence for an Increased Oxidative Stress and Carbonyl Modification of Proteins in Diabetic Glomerular Lesions.
- D. SUZUKI, T. MIYATA, N. SAOTOME, K. HORIE, R. INAGI, Y. YASUDA, K. UCHIDA, Y. IZUHARA, M. YAGAME, H. SAKAI, et al. (1999)
J. Am. Soc. Nephrol.
10, 822-832
| Abstract »
| Full Text »
- Age-Induced Protein Modifications and Increased Proteolysis in Potato Seed-Tubers.
- G.N. M. Kumar, R. L. Houtz, and N. R. Knowles (1999)
Plant Physiology
119, 89-100
| Abstract »
| Full Text »
- Metabolic Delivery of Ketone Groups to Sialic Acid Residues. APPLICATION TO CELL SURFACE GLYCOFORM ENGINEERING.
- K. J. Yarema, L. K. Mahal, R. E. Bruehl, E. C. Rodriguez, and C. R. Bertozzi (1998)
J. Biol. Chem.
273, 31168-31179
| Abstract »
| Full Text »
| PDF »
- Influence of Glycation on LDL-Induced Generation of Fibrinolytic Regulators in Vascular Endothelial Cells.
- J. Zhang, S. Ren, D. Sun, and G. X. Shen (1998)
Arterioscler. Thromb. Vasc. Biol.
18, 1140-1148
| Abstract »
| Full Text »
| PDF »
- Epitopes close to the apolipoprotein B low density lipoprotein receptor-binding site are modified by advanced glycation end products.
- X. Wang, R. Bucala, and R. Milne (1998)
PNAS
95, 7643-7647
| Abstract »
| Full Text »
| PDF »
- Breakers of advanced glycation end products restore large artery properties in experimental diabetes.
- B. H. R. Wolffenbuttel, C. M. Boulanger, F. R. L. Crijns, M. S. P. Huijberts, P. Poitevin, G. N. M. Swennen, S. Vasan, J. J. Egan, P. Ulrich, A. Cerami, et al. (1998)
PNAS
95, 4630-4634
| Abstract »
| Full Text »
| PDF »
- AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.
- A. Bierhaus, M. A Hofmann, R. Ziegler, and P. P Nawroth (1998)
Cardiovasc Res
37, 586-600
| Abstract »
| Full Text »
| PDF »
- Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy.
- B. Corman, M. Duriez, P. Poitevin, D. Heudes, P. Bruneval, A. Tedgui, and B. I. Levy (1998)
PNAS
95, 1301-1306
| Abstract »
| Full Text »
| PDF »
- Effects of Metformin on Collagen Glycation and Diastolic Dysfunction in Diabetic Myocardium.
- G.N. Jyothirmayi, B.J. Soni, M. Masurekar, M. Lyons, and T.J. Regan (1998)
Journal of Cardiovascular Pharmacology and Therapeutics
3, 319-326
| Abstract »
| PDF »
- TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms.
- N. K. Worrall, K. Chang, W. S. Lejeune, T. P. Misko, P. M. Sullivan, T. B. Ferguson Jr., and J. R. Williamson (1997)
Am J Physiol Heart Circ Physiol
273, H2565-H2574
| Abstract »
| Full Text »
| PDF »
- Myocardial Stiffness Is Attributed to Alterations in Cross-Linked Collagen Rather Than Total Collagen or Phenotypes in Spontaneously Hypertensive Rats.
- G. R. Norton, J. Tsotetsi, B. Trifunovic, C. Hartford, G. P. Candy, and A. J. Woodiwiss (1997)
Circulation
96, 1991-1998
| Abstract »
| Full Text »
- Inhibitory Effects of Tenilsetam on the Maillard Reaction.
- H. Shoda, S. Miyata, B.-F. Liu, H. Yamada, T. Ohara, K. Suzuki, M. Oimomi, and M. Kasuga (1997)
Endocrinology
138, 1886-1892
| Abstract »
| Full Text »
| PDF »
- In Vitro Kinetic Studies of Formation of Antigenic Advanced Glycation End Products (AGEs). NOVEL INHIBITION OF POST-AMADORI GLYCATION PATHWAYS.
- A. A. Booth, R. G. Khalifah, P. Todd, and B. G. Hudson (1997)
J. Biol. Chem.
272, 5430-5437
| Abstract »
| Full Text »
| PDF »
- Long Term Effects of Aminoguanidine on Insulin Release and Biosynthesis: Evidence That the Formation of Advanced Glycosylation End Products Inhibits B Cell Function.
- Y. Tajiri, C. Moller, and V. Grill (1997)
Endocrinology
138, 273-280
| Abstract »
| Full Text »
| PDF »
- Inhibition of Inducible Nitric Oxide Synthase Attenuates Established Acute Cardiac Allograft Rejection.
- N. K. Worrall, T. P. Misko, P. M. Sullivan, J.-J. Hui, and T. B. Ferguson Jr (1996)
Ann. Thorac. Surg.
62, 378-385
| Abstract »
| Full Text »
- Involvement of Hydrogen Peroxide in Collagen Cross-linking by High Glucose in Vitro and in Vivo.
- A. Elgawish, M. Glomb, M. Friedlander, and V. M. Monnier (1996)
J. Biol. Chem.
271, 12964-12971
| Abstract »
| Full Text »
| PDF »
- Aminoguanidine Prevents the Decreased Myocardial Compliance Produced by Streptozotocin-Induced Diabetes Mellitus in Rats.
- G. R. Norton, G. Candy, and A. J. Woodiwiss (1996)
Circulation
93, 1905-1912
| Abstract »
| Full Text »
- Inhibition of Inducible Nitric Oxide Synthase Prevents Myocardial and Systemic Vascular Barrier Dysfunction During Early Cardiac Allograft Rejection.
- N. K. Worrall, K. Chang, G. M. Suau, W. S. Allison, T. P. Misko, P. M. Sullivan, R. G. Tilton, J. R. Williamson, and T. B. Ferguson Jr (1996)
Circ. Res.
78, 769-779
| Abstract »
| Full Text »
- The Advanced Glycation End Product, N[IMAGE]-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions.
- M.-X. Fu, J.ús R. Requena, A. J. Jenkins, T. J. Lyons, J. W. Baynes, and S. R. Thorpe (1996)
J. Biol. Chem.
271, 9982-9986
| Abstract »
| Full Text »
| PDF »
- Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard Reaction.
- M. A. Glomb and V. M. Monnier (1995)
J. Biol. Chem.
270, 10017-10026
| Abstract »
| Full Text »
| PDF »
- Aminoguanidine Has Both Pro-oxidant and Antioxidant Activity Toward LDL.
- A. Philis-Tsimikas, S. Parthasarathy, S. Picard, W. Palinski, and J. L. Witztum (1995)
Arterioscler. Thromb. Vasc. Biol.
15, 367-376
| Abstract »
| Full Text »
- Matrix Nonenzymatic Glycosylation Leads to Altered Cellular Phenotype and Intracellular Tyrosine Phosphorylation.
- G. Hasegawa, A. J. Hunter, and A. S. Charonis (1995)
J. Biol. Chem.
270, 3278-3283
| Abstract »
| Full Text »
| PDF »
- Novel Degradation Pathway of Glycated Amino Acids into Free Fructosamine by a Pseudomonas sp. Soil Strain Extract.
- C. Gerhardinger, M. S. Marion, A. Rovner, M. Glomb, and V. M. Monnier (1995)
J. Biol. Chem.
270, 218-224
| Abstract »
| Full Text »
| PDF »
- Hemoglobin-AGE: a circulating marker of advanced glycosylation.
- Z Makita, H Vlassara, E Rayfield, K Cartwright, E Friedman, R Rodby, A Cerami, and R Bucala (1992)
Science
258, 651-653
| Abstract »
| PDF »
- Chelating Activity of Advanced Glycation End-product Inhibitors.
- D. L. Price, P. M. Rhett, S. R. Thorpe, and J. W. Baynes (2001)
J. Biol. Chem.
276, 48967-48972
| Abstract »
| Full Text »
| PDF »
|
|